Showing posts with label Pediatric drugs impact factor. Show all posts
Showing posts with label Pediatric drugs impact factor. Show all posts

Tuesday, 3 December 2013

Pediatric Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019

Transparency Market Research
Pediatric drugs are a special class of drugs which are prescribed to children and infants for different diseases.  These drugs are recommended in various conditions such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, attention deficit hyperactivity disorder, and others. Various acts have been passed to control pediatric drugs such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA). These acts have been introduced to increase the investments on R&D for pediatric drugs and to increase the drugs count prescribed for children and infants.


Pediatric drugs are categorized in three segments namely pediatric clinical pharmacology, pediatric pharmacotherapy and pediatric pharmacy. Pediatric pharmacotherapy focuses on those drugs which will behave differently in children and adults. Pediatric clinical pharmacology includes those drugs which are helpful for mental and physical growth. Pediatric pharmacy includes all those drugs which are specifically meant for children. To treat various disease conditions different drugs are prescribed such as acetaminophen, fentanyl, ibuprofen, naloxone and methadone are given as analgesics. In addition, cefazolin, ampicillin and meropenem are prescribed to treat microbial infections whereas clonidine and etomidate are recommended for sedative effect. Various other drugs are tramadole, oxycodone, codeine, lorazepam and gabapentin.

Growing concerns globally, amongst parents has assisted the growth of this segment. Moreover, governments worldwide are funding and initiating various national programs to support use of drugs to curb infant and child mortality rates. Rise in disposable income along with awareness in people has augmented the growth of pediatric drugs in developed nations such as U.S. and Europe. In addition, rising incidence of disease conditions such as obesity, diabetes and hypertension in children have also contributed in its growth. Despite various developments, low disposable income and unawareness in developing nations are hindering the growth of this market. Moreover, side effects such as anxiety, headache and fatigue are also restricting its growth.

Some of the major market players of pediatric drug include InfaCare Inc., Medeira Therapeutics, Crucell Biologics Inc., Actelion Pharma ceuticals Ltd. and other significant players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. 

Geographies analyzed under this research report include 
·         North America 
·         Asia Pacific 
·         Europe
·         Rest of the World  

This report provides comprehensive analysis of 
·         Market growth drivers 
·         Factors limiting market growth
·         Current market trends 
·         Market structure
·         Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 


About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.


Contact Us

Sheela AK
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030

Browse Market Research Blog:
http://businessindustryresearch.wordpress.com